168 related articles for article (PubMed ID: 26853466)
1. HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.
Peixoto P; Blomme A; Costanza B; Ronca R; Rezzola S; Palacios AP; Schoysman L; Boutry S; Goffart N; Peulen O; Maris P; Di Valentin E; Hennequière V; Bianchi E; Henry A; Meunier P; Rogister B; Muller RN; Delvenne P; Bellahcène A; Castronovo V; Turtoi A
Oncogene; 2016 Aug; 35(34):4481-94. PubMed ID: 26853466
[TBL] [Abstract][Full Text] [Related]
2. The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells.
Turtoi A; Mottet D; Matheus N; Dumont B; Peixoto P; Hennequière V; Deroanne C; Colige A; De Pauw E; Bellahcène A; Castronovo V
Angiogenesis; 2012 Dec; 15(4):543-54. PubMed ID: 22584896
[TBL] [Abstract][Full Text] [Related]
3. EGFR signaling is differentially activated in patient-derived glioblastoma stem cells.
Howard BM; Gursel DB; Bleau AM; Beyene RT; Holland EC; Boockvar JA
J Exp Ther Oncol; 2010; 8(3):247-60. PubMed ID: 20734923
[TBL] [Abstract][Full Text] [Related]
4. Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation.
Lei Y; Liu L; Zhang S; Guo S; Li X; Wang J; Su B; Fang Y; Chen X; Ke H; Tao W
Mol Cancer; 2017 Nov; 16(1):170. PubMed ID: 29126425
[TBL] [Abstract][Full Text] [Related]
5. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
6. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
de la Iglesia N; Konopka G; Puram SV; Chan JA; Bachoo RM; You MJ; Levy DE; Depinho RA; Bonni A
Genes Dev; 2008 Feb; 22(4):449-62. PubMed ID: 18258752
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
Ren Y; Zhou X; Mei M; Yuan XB; Han L; Wang GX; Jia ZF; Xu P; Pu PY; Kang CS
BMC Cancer; 2010 Jan; 10():27. PubMed ID: 20113523
[TBL] [Abstract][Full Text] [Related]
8. Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells.
Buendia Duque M; Pinheiro KV; Thomaz A; da Silva CA; Freire NH; Brunetto AT; Schwartsmann G; Jaeger M; de Farias CB; Roesler R
J Mol Neurosci; 2019 May; 68(1):49-57. PubMed ID: 30887411
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition.
Liffers K; Kolbe K; Westphal M; Lamszus K; Schulte A
Target Oncol; 2016 Feb; 11(1):29-40. PubMed ID: 26032687
[TBL] [Abstract][Full Text] [Related]
10. LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression.
Yao ZG; Li WH; Hua F; Cheng HX; Zhao MQ; Sun XC; Qin YJ; Li JM
J Neuropathol Exp Neurol; 2017 Dec; 76(12):1000-1007. PubMed ID: 29136455
[TBL] [Abstract][Full Text] [Related]
11. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
[TBL] [Abstract][Full Text] [Related]
12. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.
de la Iglesia N; Konopka G; Lim KL; Nutt CL; Bromberg JF; Frank DA; Mischel PS; Louis DN; Bonni A
J Neurosci; 2008 Jun; 28(23):5870-8. PubMed ID: 18524891
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.
Wang MY; Lu KV; Zhu S; Dia EQ; Vivanco I; Shackleford GM; Cavenee WK; Mellinghoff IK; Cloughesy TF; Sawyers CL; Mischel PS
Cancer Res; 2006 Aug; 66(16):7864-9. PubMed ID: 16912159
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis.
Mottet D; Bellahcène A; Pirotte S; Waltregny D; Deroanne C; Lamour V; Lidereau R; Castronovo V
Circ Res; 2007 Dec; 101(12):1237-46. PubMed ID: 17947801
[TBL] [Abstract][Full Text] [Related]
16. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
17. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.
Xu W; Bi Y; Kong J; Zhang J; Wang B; Li K; Tian M; Pan X; Shi B; Gu J; Jiang H; Kong X; Li Z
Oncotarget; 2016 Apr; 7(17):24752-65. PubMed ID: 27029073
[TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma.
Chen H; Shen X; Guo C; Zhu H; Zhou L; Zhu Y; Wang H; Zheng Y; Huang L
Cancer Biother Radiopharm; 2010 Dec; 25(6):713-21. PubMed ID: 21204766
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
